Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00170014 · ClinicalTrials.gov registry record · Phase 3
Precision of the Magnetocardiographer for Data Aquision and Analysis.
A Phase 3 study of Myocardial Ischemia, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 3
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT00170014: Completed Phase 3 study of Myocardial Ischemia, sponsored by Mayo Clinic.
NCT00170014 is a Phase 3 study of Myocardial Ischemia that has completed, run by Mayo Clinic. The registered enrollment target is 12 participants, below the 2,137-participant average among 29 other Myocardial Ischemia trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00170014, a Phase 3 study of Myocardial Ischemia, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
magnetocardiography has been extensively studied focusing on the possible clinical applications of the device. Evaluating the precision of a device is a prerequisite condition to know what are significant changes and how can these be trusted. A respectable reproducibility study for the MCG measurements is crucial for this new device to be used for clinical applications. In this study, we will focus on a critical portion of the heart cycle assessing for changes in time of the computerized analysis of this phase and comparing the analysis done by two examiners.
Conditions Studied
Interventions
- DEVICE Magnetocardiograph
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2004-10 |
| Est. Completion | 2007-06 |
| Phase | Phase 3 |
What the finished NCT00170014 record still lists
NCT00170014 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 2,137-participant average among 29 other Myocardial Ischemia trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Myocardial Ischemia appearing as the primary indexed condition, and to 1 intervention - of which Magnetocardiograph is the first listed.
NCT00170014 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT00170014 about?
NCT00170014 is a clinical study titled "Precision of the Magnetocardiographer for Data Aquision and Analysis.". magnetocardiography has been extensively studied focusing on the possible clinical applications of the device. Evaluating the precision of a device is a prerequisite condition to know what are significant changes and how can these be trusted. A respectable reproducibility study for the MCG measureme...
What is the current status of trial NCT00170014?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 12 participants. The study started on 2004-10. Estimated completion is 2007-06.
What conditions does trial NCT00170014 study?
This clinical trial studies the following conditions: Myocardial Ischemia.
What interventions are being tested in trial NCT00170014?
The interventions under investigation include: Magnetocardiograph (DEVICE).
Who is sponsoring clinical trial NCT00170014?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00170014 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myocardial Ischemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00170014's enrollment target sits among peer trials
12 29th of 29 higher than 1 of 29 other Myocardial Ischemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myocardial Ischemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome
COMPLETED · Phase 3
-
Electromechanical Mapping to Evaluate Heart Muscle
COMPLETED · Phase 3
-
SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary Syndromes
COMPLETED · Phase 3
-
A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG
COMPLETED · Phase 3
-
Safety and Efficacy of MCG for Diagnosing Coronary Heart Disease
COMPLETED · Phase 3
-
Bright Light Exposure in Surgical Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia